These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 14693172

  • 1. Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates.
    Klinkhardt U, Kuczka K, Harder S.
    Thromb Res; 2003; 111(4-5):251-7. PubMed ID: 14693172
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin.
    Storey RF, Judge HM, Wilcox RG, Heptinstall S.
    Thromb Haemost; 2002 Sep; 88(3):488-94. PubMed ID: 12353080
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators.
    Graff J, Klinkhardt U, Harder S.
    Thromb Res; 2004 Sep; 113(5):295-302. PubMed ID: 15183041
    [Abstract] [Full Text] [Related]

  • 5. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
    Judge HM, Buckland RJ, Holgate CE, Storey RF.
    Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
    [Abstract] [Full Text] [Related]

  • 6. Enhanced platelet aggregation and activation under conditions of hypothermia.
    Xavier RG, White AE, Fox SC, Wilcox RG, Heptinstall S.
    Thromb Haemost; 2007 Dec; 98(6):1266-75. PubMed ID: 18064324
    [Abstract] [Full Text] [Related]

  • 7. Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate.
    Goto S, Tamura N, Eto K, Ikeda Y, Handa S.
    Circulation; 2002 May 28; 105(21):2531-6. PubMed ID: 12034661
    [Abstract] [Full Text] [Related]

  • 8. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.
    Zhao L, Bath P, Heptinstall S.
    Br J Pharmacol; 2001 Sep 28; 134(2):353-8. PubMed ID: 11564653
    [Abstract] [Full Text] [Related]

  • 9. Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor.
    Gerrits AJ, Jakubowski JA, Sugidachi A, Michelson AD, Frelinger AL.
    J Thromb Haemost; 2017 May 28; 15(5):858-867. PubMed ID: 28092426
    [Abstract] [Full Text] [Related]

  • 10. Na(+)/H(+) exchanger in the regulation of platelet activation and paradoxical effects of cariporide.
    Chang HB, Gao X, Nepomuceno R, Hu S, Sun D.
    Exp Neurol; 2015 Oct 28; 272():11-6. PubMed ID: 25595121
    [Abstract] [Full Text] [Related]

  • 11. The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease.
    Jakubowski JA, Zhou C, Winters KJ, Lachno DR, Howard J, Payne CD, Mant T, Jurcevic S, Frelinger AL.
    Platelets; 2015 Oct 28; 26(5):474-9. PubMed ID: 25140584
    [Abstract] [Full Text] [Related]

  • 12. Sodium/hydrogen exchange inhibition with cariporide reduces leukocyte adhesion via P-selectin suppression during inflammation.
    Buerke U, Pruefer D, Carter JM, Russ M, Schlitt A, Prondzinsky R, Makowski J, Rohrbach S, Niemann B, Schulze C, Dahm M, Vahl CF, Werdan K, Buerke M.
    Br J Pharmacol; 2008 Apr 28; 153(8):1678-85. PubMed ID: 18332863
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1.
    Fox SC, Behan MW, Heptinstall S.
    Cell Calcium; 2004 Jan 28; 35(1):39-46. PubMed ID: 14670370
    [Abstract] [Full Text] [Related]

  • 14. P-selectin (CD62p) and P-selectin glycoprotein ligand-1 (PSGL-1) polymorphisms: minor phenotypic differences in the formation of platelet-leukocyte aggregates and response to clopidogrel.
    Klinkhardt U, Dragutinovic I, Harder S.
    Int J Clin Pharmacol Ther; 2005 Jun 28; 43(6):255-63. PubMed ID: 15968882
    [Abstract] [Full Text] [Related]

  • 15. The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation.
    Ruef J, Kuehnl P, Meinertz T, Merten M.
    Platelets; 2008 Aug 28; 19(5):359-64. PubMed ID: 18791942
    [Abstract] [Full Text] [Related]

  • 16. Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y12 antagonists.
    Boncler M, Wzorek J, Wolska N, Polak D, Watala C, Rozalski M.
    Vascul Pharmacol; 2019 Feb 28; 113():47-56. PubMed ID: 30471364
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of inhibition of P2Y(1) and P2Y(12) on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry.
    Ramström S, Rånby M, Lindahl TL.
    Thromb Res; 2003 Mar 15; 109(5-6):315-22. PubMed ID: 12818256
    [Abstract] [Full Text] [Related]

  • 19. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
    Merten M, Beythien C, Gutensohn K, Kühnl P, Meinertz T, Thiagarajan P.
    Arterioscler Thromb Vasc Biol; 2005 Jan 15; 25(1):258-63. PubMed ID: 15528476
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.